(EDEN) Edenred - Ratings and Ratios
Food,Vouchers,Fuel,Payment,Platform
Description: EDEN Edenred
Edenred SE operates a digital platform that provides a range of services and payment solutions for companies, employees, and merchants globally. The companys employee benefit solutions, such as Ticket Restaurant and Ticket Alimentación, allow employees to make purchases at partner merchants, while solutions like Edenred Regalo and Kadéos Culture provide gift vouchers and cultural experiences.
The companys mobility solutions, including Ticket Car, Empresarial, and UTA Edenred, enable companies to manage employee expenses and reimburse business travel costs. Additionally, Edenreds complementary solutions, such as corporate payment and incentive & rewards programs, support companies in managing their expenses and motivating employees.
Some key performance indicators (KPIs) that can be used to evaluate Edenreds performance include revenue growth, employee benefit solution penetration, and merchant adoption rates. The companys diversified revenue streams, including employee benefits, mobility solutions, and corporate payments, can help mitigate risks. With a market capitalization of approximately 6.4 billion EUR, Edenred is a significant player in the diversified support services industry.
From a financial perspective, Edenreds P/E ratio of 13.19 and forward P/E of 10.40 suggest that the company may be undervalued relative to its earnings growth potential. However, the negative return on equity (RoE) of -97.11 is a concern and warrants further investigation. Analyzing the companys revenue segmentation, geographic presence, and competitive positioning can provide additional insights into its growth prospects and profitability.
EDEN Stock Overview
| Market Cap in USD | 6,038m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception |
EDEN Stock Ratings
| Growth Rating | -71.1% |
| Fundamental | 81.3% |
| Dividend Rating | 70.3% |
| Return 12m vs S&P 500 | -50.6% |
| Analyst Rating | - |
EDEN Dividends
| Dividend Yield 12m | 4.96% |
| Yield on Cost 5y | 3.40% |
| Annual Growth 5y | 9.46% |
| Payout Consistency | 92.7% |
| Payout Ratio | 58.5% |
EDEN Growth Ratios
| Growth Correlation 3m | -64.1% |
| Growth Correlation 12m | -76.8% |
| Growth Correlation 5y | -27.5% |
| CAGR 5y | -22.18% |
| CAGR/Max DD 3y | -0.34 |
| CAGR/Mean DD 3y | -1.01 |
| Sharpe Ratio 12m | 0.78 |
| Alpha | 0.00 |
| Beta | 0.992 |
| Volatility | 41.80% |
| Current Volume | 982k |
| Average Volume 20d | 634.9k |
| Stop Loss | 19.7 (-3.2%) |
| Signal | -0.11 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (807.0m TTM) > 0 and > 6% of Revenue (6% = 310.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 9.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -27.66% (prev -12.59%; Δ -15.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.51b > Net Income 807.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.76b) to EBITDA (2.06b) ratio: 1.82 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (247.6m) change vs 12m ago -6.36% (target <= -2.0% for YES) |
| Gross Margin 47.01% (prev 54.88%; Δ -7.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.00% (prev 20.22%; Δ 19.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.73 (EBITDA TTM 2.06b / Interest Expense TTM 282.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.45
| (A) -0.11 = (Total Current Assets 8.55b - Total Current Liabilities 9.98b) / Total Assets 13.32b |
| (B) -0.14 = Retained Earnings (Balance) -1.86b / Total Assets 13.32b |
| (C) 0.12 = EBIT TTM 1.62b / Avg Total Assets 12.95b |
| (D) -0.12 = Book Value of Equity -1.79b / Total Liabilities 14.37b |
| Total Rating: -0.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.27
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 15.47% = 5.0 |
| 3. FCF Margin 28.20% = 7.05 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 2.50 = -0.96 |
| 6. ROIC - WACC (= 25.68)% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend 52.88% = 3.97 |
| 9. EPS Trend 34.28% = 1.71 |
What is the price of EDEN shares?
Over the past week, the price has changed by -8.33%, over one month by -22.24%, over three months by -19.12% and over the past year by -41.49%.
Is Edenred a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EDEN is around 17.85 EUR . This means that EDEN is currently overvalued and has a potential downside of -12.29%.
Is EDEN a buy, sell or hold?
What are the forecasts/targets for the EDEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.1 | 92.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 19.4 | -4.8% |
EDEN Fundamental Data Overview
Market Cap EUR = 5.11b (5.11b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 827.0m EUR (last quarter)
P/E Trailing = 10.0821
P/E Forward = 8.0515
P/S = 1.909
P/EG = 0.8132
Beta = 0.565
Revenue TTM = 5.18b EUR
EBIT TTM = 1.62b EUR
EBITDA TTM = 2.06b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last quarter)
Debt = 5.16b EUR (Calculated: Short Term 1.27b + Long Term 3.88b)
Net Debt = 3.76b EUR (from netDebt column, last quarter)
Enterprise Value = 9.44b EUR (5.11b + Debt 5.16b - CCE 827.0m)
Interest Coverage Ratio = 5.73 (Ebit TTM 1.62b / Interest Expense TTM 282.0m)
FCF Yield = 15.47% (FCF TTM 1.46b / Enterprise Value 9.44b)
FCF Margin = 28.20% (FCF TTM 1.46b / Revenue TTM 5.18b)
Net Margin = 15.59% (Net Income TTM 807.0m / Revenue TTM 5.18b)
Gross Margin = 47.01% ((Revenue TTM 5.18b - Cost of Revenue TTM 2.74b) / Revenue TTM)
Tobins Q-Ratio = -5.27 (set to none) (Enterprise Value 9.44b / Book Value Of Equity -1.79b)
Interest Expense / Debt = 2.02% (Interest Expense 104.0m / Debt 5.16b)
Taxrate = 31.79% (254.0m / 799.0m)
NOPAT = 1.10b (EBIT 1.62b * (1 - 31.79%))
Current Ratio = 0.86 (Total Current Assets 8.55b / Total Current Liabilities 9.98b)
Debt / EBITDA = 2.50 (Net Debt 3.76b / EBITDA 2.06b)
Debt / FCF = 3.53 (Debt 5.16b / FCF TTM 1.46b)
Total Stockholder Equity = -921.8m (last 4 quarters mean)
RoA = 6.06% (Net Income 807.0m, Total Assets 13.32b )
RoE = unknown (Net Income TTM 807.0m / Total Stockholder Equity -921.8m)
RoCE = 54.57% (Ebit 1.62b / (Equity -921.8m + L.T.Debt 3.88b))
RoIC = 31.19% (NOPAT 1.10b / Invested Capital 3.54b)
WACC = 5.50% (E(5.11b)/V(10.27b) * Re(9.67%)) + (D(5.16b)/V(10.27b) * Rd(2.02%) * (1-Tc(0.32)))
Shares Correlation 3-Years: 1.55 | Cagr: -0.55%
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.94% ; FCFE base≈949.0m ; Y1≈825.6m ; Y5≈663.0m
Fair Price DCF = 38.76 (DCF Value 9.23b / Shares Outstanding 238.0m; 5y FCF grow -15.89% → 3.0% )
EPS Correlation: 34.28 | EPS CAGR: 196.3% | SUE: -0.47 | # QB: 0
Revenue Correlation: 52.88 | Revenue CAGR: 26.21% | SUE: N/A | # QB: None